Indipharm (India) Private Limited
About Indipharm (India) Private Limited
Data last updated:
Indipharm (India) Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Inclinica Inc. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the technical testing segment of the professional services sector. It was incorporated on 02 April 2008.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC180716. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Milind Sitaram Desai and Edward Joseph Brennan.
Its last annual general meeting (AGM) was held on 04 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 1/5 Shah Building 115 Kataria Marg Mahim, Mumbai, Maharashtra, India – 400016.
Company details
Contact details
Indipharm (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/5 Shah Building 115 Kataria Marg Mahim, Mumbai, Maharashtra, India – 400016
- IndustryProfessional Services, Technical Testing, Engineering Activities, Architecture
To see the full contact details of Indipharm (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indipharm (India) is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
Financials of Indipharm (India) Private Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Indipharm (India) Private Limited, buy the company report.
Board of directors of Indipharm (India) Private Limited
Indipharm (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milind Sitaram Desai | Director | 02 Apr 2008 | 18 Years 6 Months | As last reported |
| Edward Joseph Brennan | Director | 02 Apr 2008 | 18 Years 6 Months | As last reported |
Auditor
Indipharm (India) Private Limited is audited by Vipul H Mehta for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vipul H Mehta | FY 2017 | 122591 |
Shareholding
The shareholding of Indipharm (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Indipharm (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indipharm (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indipharm (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indipharm (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Indipharm (India) Private Limited, buy the company report.
Recent activity
Indipharm (India) Private Limited has 3 board changes on record since 2008: 2 appointments and 1 cessation. The latest: Dilip Rajaram Limaye ceased to be Director on 18 Mar 2016.
Frequently asked questions
Indipharm (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Indipharm (India) was a private limited company based in Mumbai, Maharashtra, India. The company worked in technical testing, within the professional services industry. It was incorporated on 02 April 2008 and is registered under CIN U24239MH2008PTC180716. The company has been struck off by the Registrar of Companies and is no longer operational.
Indipharm (India) had 2 directors:
- Milind Sitaram Desai - Director
- Edward Joseph Brennan - Director
The CIN (Corporate Identification Number) of Indipharm (India) is U24239MH2008PTC180716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Indipharm (India) is at 15 Shah Building 115 Kataria Marg Mahim, Mumbai, Maharashtra, India – 400016.
Indipharm (India) was incorporated on 02 April 2008. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Indipharm (India) on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 04 September 2017. Year-wise statements from 2015 are in the company report.
No. Indipharm (India) has 1 GST registration on record and it is cancelled or inactive.
Indipharm (India) operated in the professional services industry, in the technical testing segment. It worked in this industry before it was struck off.
Dilip Rajaram Limaye ceased to be Director on 18 Mar 2016. Edward Joseph Brennan was appointed as Director on 02 Apr 2008. Milind Sitaram Desai was appointed as Director on 02 Apr 2008.